We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
-6.96%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$20.1B
AUM Growth
-$1.42B
Cap. Flow
+$722M
Cap. Flow %
3.6%
Top 10 Hldgs %
32.25%
Holding
923
New
53
Increased
381
Reduced
447
Closed
40

Sector Composition

Rank Sector Weight
1 Materials 53.66%
2 Energy 20.54%
3 Healthcare 5.93%
4 Technology 2.53%
5 Industrials 2.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESV
101
DELISTED
Ensco Rowan plc
ESV
$32.5M 0.16%
835,261
-71,597
-8% -$2.57M
GSS
102
DELISTED
Golden Star Resources Ltd.
GSS
$32.4M 0.16%
+8,699,023
New +$34.4M
SA
103
Seabridge Gold
SA
$2.8B
$32.4M 0.16%
3,970,720
-2,225,426
-36% -$21.9M
JNJ icon
104
Johnson & Johnson
JNJ
$635B
$32.2M 0.16%
279,278
+143,016
+105% +$16.5M
COR icon
105
Cencora
COR
$60.3B
$30.6M 0.15%
391,138
+4,771
+1% +$372K
DRD
106
DRDGold
DRD
$1.82B
$30.2M 0.15%
+5,708,090
New +$26.7M
VEON icon
107
VEON
VEON
$3.53B
$30.1M 0.15%
312,692
+186,263
+147% +$16.1M
GORO icon
108
Goldgroup Mining Inc.
GORO
$151M
$30.1M 0.15%
6,914,702
-1,616,094
-19% -$7.97M
PFE icon
109
Pfizer
PFE
$140B
$29.8M 0.15%
968,004
+606,053
+167% +$18.5M
HTHT icon
110
Huazhu Hotels Group
HTHT
$12.4B
$27.5M 0.14%
2,125,360
-278,640
-12% -$3.28M
ILMN icon
111
Illumina
ILMN
$29.4B
$26.9M 0.13%
215,978
+50,891
+31% +$6.86M
BMRN icon
112
BioMarin Pharmaceuticals
BMRN
$11.5B
$26.2M 0.13%
316,795
+36,542
+13% +$3.14M
RIO icon
113
Rio Tinto
RIO
$148B
$26.2M 0.13%
681,167
+255,005
+60% +$9.35M
REGN icon
114
Regeneron Pharmaceuticals
REGN
$68.8B
$26M 0.13%
70,944
+3,567
+5% +$1.36M
OII icon
115
Oceaneering
OII
$5.25B
$26M 0.13%
922,115
-34,755
-4% -$936K
IQV icon
116
IQVIA
IQV
$34.7B
$25.6M 0.13%
336,924
+97,585
+41% +$7.48M
LOW icon
117
Lowe's Companies
LOW
$116B
$25.4M 0.13%
356,718
+137,576
+63% +$9.73M
INCY icon
118
Incyte
INCY
$23.5B
$25.3M 0.13%
252,072
-7,004
-3% -$683K
VRTX icon
119
Vertex Pharmaceuticals
VRTX
$121B
$25.1M 0.13%
340,586
+58,750
+21% +$4.78M
ALXN
120
DELISTED
Alexion Pharmaceuticals
ALXN
$25M 0.12%
204,643
-10,750
-5% -$1.32M
DIS icon
121
Walt Disney
DIS
$165B
$24.8M 0.12%
237,908
+20,588
+9% +$2.01M
NVDA icon
122
NVIDIA
NVDA
$5.01T
$24.7M 0.12%
9,273,640
-6,735,320
-42% -$14.1M
MOS icon
123
The Mosaic Company
MOS
$7.09B
$24.2M 0.12%
823,520
-64,748
-7% -$1.74M
BG icon
124
Bunge Global
BG
$23.6B
$24M 0.12%
331,869
-71,877
-18% -$4.79M
AVGO icon
125
Broadcom
AVGO
$1.82T
$23.3M 0.12%
1,316,960
-585,010
-31% -$10.1M

Similar funds

VanEck Associates's Q4 2016 Portfolio in Review

As of Q4 2016, VanEck Associates held 923 positions worth $20.1B, down 6.6% from $21.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

VanEck Associates deployed $722M of net new capital in Q4 2016, opening 53 new positions and adding to 381 existing holdings. Its largest new stake was Golden Star Resources Ltd.: 8,699,023 shares worth $32.4M.

By sector, the portfolio is most concentrated in Materials at 54% of assets, down from 57% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was PRETIUM RESOURCES INC., an estimated $51.9M trimmed.

  • VanEck Associates's largest Q4 2016 buy was Golden Star Resources Ltd.: 8,699,023 shares worth $32.4M.
  • VanEck Associates added most to Barrick Mining in Q4 2016, an estimated $146M increase.
  • VanEck Associates's biggest Q4 2016 reduction was PRETIUM RESOURCES INC., cutting an estimated $51.9M.
  • VanEck Associates fully exited iShares S&P Mid-Cap 400 Growth ETF in Q4 2016, selling an estimated $19.4M.
  • VanEck Associates's ten largest holdings make up 32% of its $20.1B portfolio in Q4 2016.
  • VanEck Associates opened 53 new positions and closed 40 in Q4 2016.
  • VanEck Associates's portfolio value fell 6.6% quarter-over-quarter to $20.1B.

Based on VanEck Associates's 13F filing for Q4 2016, filed 9 Feb 2017.